Abstracts tagged "quality improvement and rheumatoid arthritis (RA)"

Abstract Number: 324 • 2018 ACR/ARHP Annual Meeting
Three Health It Interventions Increased Documentation of RA Disease Activity Scores in an Academic Rheumatology Clinic: Results from an Interrupted Time Series Study
Julie Gandrup^1,2, Jing Li², Zara Izadi³, Milena Gianfrancesco², Torkell Ellingsen⁴, Jinoos Yazdany² and Gabriela Schmajuk^5,6, ¹Rheumatology, Odense University Hospital, Odense, Denmark, ²Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ³Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ⁴Department of Rheumatology, Odense University Hospital, Odense, Denmark, ⁵San Francisco VA Medical Center, San Francisco, CA, ⁶Medicine/Rheumatology, University of California - San Francisco, San Francisco, CA
Background/Purpose: Regular assessment of disease activity is a fundamental part of high quality RA care. Customization of electronic health records (EHRs) can facilitate the systematic…
Abstract Number: 1814 • 2017 ACR/ARHP Annual Meeting
Time Trends over a Decade Show Earlier Intensified Medication Strategies and Improved Outcomes in Canadians with Early Inflammatory Arthritis
Orit Schieir¹, Marie-France Valois², Susan J. Bartlett^3,4, Carol A Hitchon⁵, Janet E. Pope⁶, Gilles Boire⁷, Boulos Haraoui⁸, Diane Tin⁹, Carter Thorne¹⁰, Edward C. Keystone^11,12 and Vivian P. Bykerk^13,14, ¹Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, ²McGill University, Montreal, QC, Canada, ³Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ⁴Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁵University of Manitoba, Winnipeg, MB, Canada, ⁶Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ⁷Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, ⁸Institute de Rheumatologie, Montreal, QC, Canada, ⁹The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ¹⁰University of Toronto, Newmarket, ON, Canada, ¹¹University of Toronto, Toronto, ON, Canada, ¹²Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, ¹³Mount Sinai Hospital, Toronto, ON, Canada, ¹⁴Divison of Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Treatment recommendations aim to improve outcomes in rheumatoid arthritis (RA) through early identification and a treat-to-target approach. We examined recent trends over the past…
Abstract Number: 1081 • 2017 ACR/ARHP Annual Meeting
Improving Patient-Reported Outcomes Collection and Documentation for Patients with Rheumatoid Arthritis at Multilingual, Safety Net Hospital Rheumatology Clinic
Todd Liou¹, Omotoke Odimayomi¹, Laura Trupin², Jinoos Yazdany² and Mary Margaretten³, ¹University of California San Francisco, San Francisco, CA, ²Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, ³Medicine, University of California San Francisco, San Francisco, CA
Background/Purpose: The Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function-10a (PF10a) survey is a reliable and valid measure of function in patients with rheumatoid arthritis…
Abstract Number: 1416 • 2016 ACR/ARHP Annual Meeting
Sustained Improvement in Documentation of Disease Activity Measurement As a Quality Improvement Project at an Academic Rheumatology Clinic
Melissa Wells¹, Rebecca Sadun², Malithi Jayasundara¹, Nicholas Holdgate¹, Samya Mohammad¹, Jason Weiner¹, Tayseer Haroun¹, Stephen Balevic², Lisa Criscione-Schrieber¹ and Mala Kaul¹, ¹Rheumatology, Duke University Medical Center, Durham, NC, ²Rheumatology Adult and Pediatric, Duke University Medical Center, Durham, NC
Background/Purpose: Measurement of disease activity is considered a quality measure for management of rheumatoid arthritis (RA) patients. One validated measure of RA disease activity is…
Abstract Number: 2523 • 2016 ACR/ARHP Annual Meeting
Reasons for Provider Non-Adherence to a Treat to Target Strategy in Rheumatoid Arthritis
Agnes Zak¹, Cassandra Corrigan¹, Liana Fraenkel², Leslie R. Harrold³, Jeffrey N. Katz⁴, Sara Lee¹, Theodore Pincus⁵, Josef S. Smolen⁶ and Daniel H. Solomon⁷, ¹Brigham and Women's Hospital, Boston, MA, ²Yale University School of Medicine, New Haven, CT, ³University of Massachusetts Medical School, Worcester, MA, ⁴Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, ⁵Rheumatology, Rush University Medical Center, Chicago, IL, ⁶Medical University of Vienna, Vienna, Austria, ⁷Division of Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Provider adherence to a Treat to Target (TTT) strategy for management of rheumatoid arthritis (RA) requires setting a disease target, regular monitoring of disease…
Abstract Number: 115 • 2015 ACR/ARHP Annual Meeting
Validation of a Large Rheumatoid Arthritis Cohort and Preventive Health Screening
Michael Grasso¹, Dana Direnzo², Yelena Yesha³, Naphtali Rishe⁴ and Amanda Niskar⁵, ¹Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, ²Internal Medicine, University of Maryland Medical Center, Baltimore, MD, ³Computer Science and Electrical Engineering, Professor, Baltimore, MD, ⁴Computer Science, Florida International University, Miami, FL, ⁵1330 West Peachtree Street NW, Arthritis Foundation, Atlanta, GA
Background/Purpose: We extracted a large cohort of rheumatoid arthritis (RA) patients, on which we plan to apply big data analytics for earlier diagnosis of RA.…
Abstract Number: 133 • 2015 ACR/ARHP Annual Meeting
Advocating for Rheumatoid Arthritis and Cardiovascular Health (ARCH) in a Tertiary Referral Center: A Collaborative and Systems-Based Approach to Improve Access to Care
Barbara Goldstein¹, JoAnn Zell¹, Pearlanne Zelarney², Matthew Stern², Sarah Meadows², Meg Dingae², Carmen Egidio² and Darlene Kim², ¹Medicine, National Jewish Health, Denver, CO, ²National Jewish Health, Denver, CO
Background/Purpose: Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease (CVD) as compared to the general population. The European League Against Rheumatism…
Abstract Number: 380 • 2015 ACR/ARHP Annual Meeting
Osteoporosis Screening and Treatment of Rheumatoid Arthritis Patients at a Teaching Institution
Sheena Ogando¹, Calie Santana², Irene Blanco³ and Barbara Mendez¹, ¹Rheumatology, Montefiore Medical Center, Bronx, NY, ²Medicine, Montefiore Medical Center, Bronx, NY, ³Rheumatology, Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: Glucocorticoids are effective at treating rheumatologic diseases but are known to increase fracture risk. In 2010, the ACR developed recommendations for the prevention…
Abstract Number: 1296 • 2015 ACR/ARHP Annual Meeting
Evaluating Inter-Rater Reliability in Joint Count to Promote Quality and Trust in a Clinical Arthritis Care Team
Diane Tin¹, Lorna J. Bain¹, J Carter Thorne², Meen Jae Lee^2,3, Lois Derrick^1,4, E Jean Painter¹, Annabelle Estaban¹, Nooshin Samadi², Sue Charette¹, Sherry Hartnett¹, Carolyn Bornstein¹, Edward Ng² and Michael Aubrey², ¹The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ²Southlake Regional Health Centre, Newmarket, ON, Canada, ³Pharmacology, McGill University, Montreal, QC, Canada, ⁴The Arthritis Society, Toronto, ON, Canada
Background/Purpose: Joint count assessment is essential for the diagnosis and ongoing evaluation of Rheumatoid Arthritis (RA) disease activity. In our team based, interprofessional approach to…
Abstract Number: 2489 • 2015 ACR/ARHP Annual Meeting
Effects of Two Interventions on Rheumatologists Adherence to Optimal Care Recommendations in Rheumatoid Arthritis: A Combined before/after and Randomized Controlled Trial
Nienke Lesuis¹, Ronald van Vollenhoven², Marlies Hulscher³ and Alfons den Broeder¹, ¹Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, ²ClinTRID, Department of Medicine, Karolinska Institute, Stockholm, Sweden, ³IQ Healthcare, Radboud University Medical Centre, Nijmegen, Netherlands
Background/Purpose: Current treatment guidelines for rheumatoid arthritis (RA) recommend using tight control strategies.1 Despite evidence for the benefits of this strategy, physician adherence is suboptimal.2,3…
Abstract Number: 2490 • 2015 ACR/ARHP Annual Meeting
Implementation of Disease Activity Measurement for Rheumatoid Arthritis Patients in an Academic Rheumatology Clinic
Alison Bays¹, Elizabeth R. Wahl², David I. Daikh³, Jinoos Yazdany⁴ and Gabriela Schmajuk⁵, ¹Rheumatology, University of Washington, Seattle, WA, ²Medicine/Rheumatology, San Francisco Veterans Affairs Medical Center, San Francisco, CA, ³Rheumatology, UCSF/VA Medical Center, San Francisco, CA, ⁴Rheumatology, UCSF, SF, CA, ⁵San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA
Background/Purpose: Current recommendations for optimal rheumatoid arthritis (RA) management include routine assessment of disease activity and adjustment of medication to achieve remission or low disease…
Abstract Number: 2492 • 2015 ACR/ARHP Annual Meeting
Implementation of the Clinical Disease Activity Index to Treat to Target Rheumatoid Arthritis in the Ambulatory Setting: A Plan Do Study Act Quality Analysis
Irene Lazarus¹, Salahuddin Kazi², Alok Dwivedi³, Christopher Dodoo⁴, Riya Joseph⁵, Mariela Hernandez⁶, Cam Duong⁷, Yasmin Sabet⁸ and Kanchan Pema⁹, ¹Internal Medicine, Texas Tech University Health Science Center, El Paso, TX, ²Internal Medicine/Rheumatology, UT Southwestern Medical Center, Dallas, TX, ³Biomedical Sciences Division of Biostatistics and Epidemiology, Texas Tech University Health Sciences Center, El Paso, TX, ⁴Texas Tech University Health Sciences Center, El Paso, TX, ⁵Internal Medicine, Methodist Dallas Medical Center, Dallas, TX, ⁶Paul Foster Medical School, Texas Tech University Health Sciences Center, El Paso, TX, ⁷Paul Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, ⁸Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, ⁹Internal Medicne/Rheumatology, Texas Tech University Health Science Center, El Paso, TX
Background/Purpose: Achieving tight control of RA with reliable methods to monitor and assess disease activity in a more objective way is imperative in clinical practice…
Abstract Number: 1353 • 2014 ACR/ARHP Annual Meeting
Integrating Collection of Rheumatoid Arthritis Disease Activity and Physical Function Scores into an Academic Rheumatology Practice to Improve Quality of Care
Vladimir Chernitskiy¹, Andre DeVito², Naama Neeman², Niraj Sehgal², Jinoos Yazdany³ and Andrew J. Gross³, ¹Rheumatology, University of California, San Francisco, San Francisco, CA, ²Medicine, University of California San Francisco, San Francisco, CA, ³Medicine, University of California, San Francisco, San Francisco, CA
Background/Purpose: The default design of our institutions’ electronic health record (EHR)(Epic Systems) was not optimally structured to systematically collect quality metrics for rheumatic disease management…
Abstract Number: 673 • 2014 ACR/ARHP Annual Meeting
A Comparison of Rheumatoid Arthritis and Systemic Lupus Erythematosus Trial Design: Ways to Improve Positive Trials in Systemic Lupus Erythematosus
Amy Miles¹ and Janet E. Pope², ¹Medicine, University of Western Ontario and U of Toronto, London, ON, Canada, ²St Joseph Health Care, London, ON, Canada
Background/Purpose: Recent SLE RCTs were examined and compared to rheumatoid arthritis (RA) RCT to suggest modifications to SLE RCTs that could improve the future success…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].